About Bioneer
Bioneer is a publicly listed company based in Daejeon (South Korea) founded in 1992. Molecular biology products, technologies, and RNAi therapeutics are provided. It operates on a HealthTech model. The company has 392 employees. Its website bioneer.com draws about 17 thousand monthly visits. Bioneer offers products and services including Genomic Technology Solutions. Its focus areas include Biotechnology and Genomic Technology. Its legal entity is BIONEER CORPORATION.
Company details
Bioneer is focused on developing genomic technology solutions. Activities are centered in the biotechnology sector, targeting health improvements. Operations span across multiple regions including USA, Canada, China, and Korea. Solutions are aimed at creating a healthier future for humanity through innovative approaches.
- Headquarters Daejeon, South Korea
- Employees 392
- Stage Public
- SectorsHealthcare
- Website bioneer.com
- Social LinkedIn X
- Legal Name Bioneer Corporation
- Annual Revenue$228.58 M (USD)12.29as on Dec 31, 2025
- Net Profit-$1.95 M (USD)86.33as on Dec 31, 2025
- EBITDA$11.72 M (USD)as on Dec 31, 2025
- Employee Count392
Products & Services of Bioneer
Bioneer offers a comprehensive portfolio of products and services, including Genomic Technology Solutions.
Genomic technology solutions are provided for health advancements.
IPO & Listings of Bioneer
Bioneer is a publicly listed company on the KRX with ticker symbol 064550 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date29 Dec 2005
- Listed onKRX: 064550
- Listed entityBioneer Corporation
- Exchange sectorHealth technology
- ISINKR7064550007
- Share price7,820.00 KRW (-2.01% on the day) · 2026-10-14
- Market capitalisation205,966,124,496.00 KRW
- EPS (diluted, trailing year)-258.54 KRW
- Volume (last session)148,932
Financials of Bioneer
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 330.11B KRW | -2.81B KRW | 16.92B KRW |
| 2024 | 293.98B KRW | -20.58B KRW | -7.41B KRW |
| 2023 | 263.24B KRW | -10.59B KRW | 2.92B KRW |
| 2022 | 218.39B KRW | 12.08B KRW | 18.00B KRW |
| 2021 | 223.74B KRW | 27.16B KRW | 50.07B KRW |
Detailed financial statements for Bioneer
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Bioneer
The website of Bioneer (bioneer.com) receives about 17.1K visits a month.
- Monthly visits17.1K
▼ 13.6% vs previous month
Websites whose visitors overlap most with Bioneer. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
promega.kr | promega.kr | 100% | #1,421,820 | – | |
genome.ucsc.edu | genome.ucsc.edu | 94% | – | ||
| affymetrix.com | 94% | 1.1K | #9,164,392 | View details | |
www3.appliedbiosystems.com | www3.appliedbiosystems.com | 94% | – | ||
| alleninstitute.org | 94% | 151.4K | #270,741 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Bioneer
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioneer
Complete news archive for Bioneer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioneer
Bioneer was founded in 1992.
Bioneer is headquartered in Daejeon, South Korea.
Bioneer has 392 employees.
Annual revenue of Bioneer is $228.58M as on Dec 31, 2025.
Bioneer is focused on developing genomic technology solutions. Activities are centered in the biotechnology sector, targeting health improvements. Operations span across multiple regions including USA, Canada, China, and Korea. Solutions are aimed at creating a healthier future for humanity through innovative approaches.
Bioneer offers Genomic Technology Solutions.
Yes, Bioneer is publicly traded on KRX under the ticker symbol 064550.
Bioneer operates through Bioneer Corporation.